Cancer researchers are trying to develop drugs that trigger or enhance apoptosis,or programmed cell death,in tumor cells in which this process is suppressed.Some of the promising candidates now in clinical trials are histone deacetylase (HDAC)inhibitors such as depsipeptide FR901228,a cyclic peptide-like molecule with both ester and amide linkages.
展开▼
